Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Dandachi Nadia |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2023

Originalarbeit (Zeitschrift)

** Brcic, I; Kluba, AM; Godschachner, TM; Suppan, C; Regitnig, P; Dandachi, N; Lax, SF; Balić, M Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Int J Mol Sci. 2023; 24(1): Doi: 10.3390/ijms24010818 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Originalarbeit (Zeitschrift)

** Suppan, C; Graf, R; Jahn, S; Zhou, Q; Klocker, EV; Bartsch, R; Terbuch, A; Kashofer, K; Regitnig, P; Lindenmann, J; Posch, F; Gerritsmann, H; Jost, PJ; Heitzer, E; Dandachi, N; Balic, M Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer. 2022; 126(3):456-463 Doi: 10.1038/s41416-021-01601-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stöger, H; Greil, R Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Breast Care (Basel). 2022; 17(1): 1-9. Doi: 10.1159/000512467 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Zhou, Q; Gampenrieder, SP; Frantal, S; Rinnerthaler, G; Singer, CF; Egle, D; Pfeiler, G; Bartsch, R; Wette, V; Pichler, A; Petru, E; Dubsky, PC; Bago-Horvath, Z; Fesl, C; Rudas, M; Ståhlberg, A; Graf, R; Weber, S; Dandachi, N; Filipits, M; Gnant, M; Balic, M; Heitzer, E Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Clin Cancer Res. 2022; 28(4):697-707 Doi: 10.1158/1078-0432.CCR-21-3231 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Dandachi, N; Balic, M Deciphering the molecular landscape of metastatic lobular breast cancer
EBIOMEDICINE. 2022; 86: 104385 Doi: 10.1016/j.ebiom.2022.104385 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Originalarbeit (Zeitschrift)

** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakić, E; Richtig, G; Richtig, E; Rohrer, PM; Koch, L; Wolf, IH; Koch, C; Rainer, BM; Koeller, M; Pichler, M; Gerritsmann, H; Kashofer, K; Aigelsreiter, A Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Cancers (Basel). 2021; 13(12): Doi: 10.3390/cancers13123101 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Dandachi, N; Posch, F; Graf, R; Suppan, C; Klocker, EV; Müller, HD; Lindenmann, J; Terbuch, A; Heitzer, E; Balic, M Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR+ breast cancer patients undergoing CDK4/6 treatment.
Mol Oncol. 2021; 15(9):2390-2400 Doi: 10.1002/1878-0261.12870 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Laprovitera, N; Riefolo, M; Porcellini, E; Durante, G; Garajova, I; Vasuri, F; Aigelsreiter, A; Dandachi, N; Benvenuto, G; Agostinis, F; Sabbioni, S; Berindan, Neagoe, I; Romualdi, C; Ardizzoni, A; Trerè, D; Pichler, M; D'Errico, A; Ferracin, M MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Mol Oncol. 2021; 15(10):2732-2751 Doi: 10.1002/1878-0261.13026 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Suppan, C; Posch, F; Mueller, HD; Mischitz, N; Steiner, D; Klocker, EV; Setaffy, L; Bargfrieder, U; Hammer, R; Hauser, H; Jost, PJ; Dandachi, N; Lax, S; Balic, M Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity.
Cancers (Basel). 2021; 13(10): Doi: 10.3390/cancers13102492 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Suppan, C; Steiner, D; Klocker, EV; Posch, F; Henzinger, E; Muller, HD; Stoger, H; Dandachi, N; Balic, M Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients
BREAST CARE. 2021; Doi: 10.1159/000513766 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stoger, H; Greil, R Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)
BREAST CARE. 2021; Doi: 10.1159/000512467
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4): [Poster]
Web of Science

 

2020

Originalarbeit (Zeitschrift)

** Lindenmann, J; Fediuk, M; Fink-Neuboeck, N; Porubsky, C; Pichler, M; Brcic, L; Anegg, U; Balic, M; Dandachi, N; Maier, A; Smolle, M; Smolle, J; Smolle-Juettner, FM Hazard Curves for Tumor Recurrence and Tumor-Related Death Following Esophagectomy for Esophageal Cancer.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082066 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moritz, J; Bauernhofer, T; Mannweiler, S; Langsenlehner, T; Pummer, K; Dandachi, N; Pichler, M Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients.
In Vivo. 2020; 34(6): 3631-3638. Doi: 10.21873/invivo.12209 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G; Schuuring, E; Groen, HJM; Geigl, JB; Heitzer, E; Speicher, MR Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.
ESMO Open. 2020; 5(5):e000872 Doi: 10.1136/esmoopen-2020-000872 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakic, E; Richtig, G; Richtig, E; Rohrer, P; Koch, L; Wolf, I; Koch, C; Rainer, B; Koeller, M; Pichler, M; Kashofer, K; Aigelsreiter, A Feasibility and first results of circulating tumor DNA as a marker for treatment response in metastatic melanoma patients using Next Generation Sequencing.
ONCOL RES TREAT. 2020; 43(SUPPL 4):166-167. [Onlinepräsentation]
Web of Science

 

** Perakis, SO; Weber, S; Graf, R; Zhou, Q; Riedl, JM; Dandachi, N; Balic, M; Gerger, A; Schuuring, E; Groen, HJ; Geigl, JB; Speicher, MR; Heitzer, E Identification of actionable targets in advanced cancer patients from circulating tumor DNA using clinical decision support platforms
CANCER RES. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; ELECTR NETWORK. Doi: 10.1158/1538-7445.AM2020-1315 [Poster]
Web of Science FullText FullText_MUG

 

** Suppan, C; Steiner, D; Klocker, VE; Posch, F; Henzinger, EC; Stoeger, H; Dandachi, N; Balic, M Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
J CLIN ONCOL. 2020; 38(15): [Onlinepräsentation]
Web of Science FullText

 

** Suppan, C; Zhou, Q; Graf, R; Klocker, V; Terbuch, A; Dandachi, N; Heitzer, E; Balic, M Liquid biopsy-based detection of PIK3Ca mutations in HR positive metastastic breast cancer patients.
ANN ONCOL. 2020; 31: S41-S41.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.213 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Čipak Gašparović, A; Milković, L; Dandachi, N; Stanzer, S; Pezdirc, I; Vrančić, J; Šitić, S; Suppan, C; Balic, M Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype.
Antioxidants (Basel). 2019; 8(12): 633 Doi: 10.3390/antiox8120633 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Müller, HD; Posch, F; Suppan, C; Bargfrieder, U; Gumpoldsberger, M; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoeger, H; Lax, S; Balic, M Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
Ann Surg Oncol. 2019; 26(13):4274-4283 Doi: 10.1245/s10434-019-07741-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Suppan, C; Brcic, I; Tiran, V; Mueller, HD; Posch, F; Auer, M; Ercan, E; Ulz, P; Cote, RJ; Datar, RH; Dandachi, N; Heitzer, E; Balic, M Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.
Cancers (Basel). 2019; 11(8): Doi: 10.3390/cancers11081171 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Balic, M; Suppan, C; Brcic, I; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Dandachi, N Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment
ANN ONCOL. 2019; 30: 110-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Dandachi, N; Absenger, G; Brcic, L; Kashofer, K; Terbuch, A; Jaritz, L; Stanzer, S; Balic, M Feasibility and clinical value of serial circulating tumor DNA testing in metastatic lung adenocarcinoma patients undergoing TKI treatment
ONCOL RES TREAT. 2019; 42: 213-213. [Poster]
Web of Science

 

** Dandachi, N; Suppan, C; Brcic, L; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Balic, M Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
ONCOL RES TREAT. 2019; 42: 41-41. [Poster]
Web of Science

 

2018

Abstract (Zeitschrift)

** Balic, M; Mueller, DH; Hammer, R; Gumpoldsberger, M; Suppan, C; Posch, F; Stoeger, H; Dandachi, N; Prein, K; Hauser, H; Lax, S Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX. [Poster]
Web of Science

 

** Gasparovic, AC; Milkovic, L; Sitic, S; Pezdirc, I; Vrancic, J; Stanzer, S; Dandachi, N; Balic, M Role of 4-hydroxynonenal in communication between cancer stem cells and microenvironment
FREE RADICAL BIO MED. . 2018; 124: 563-563.-International HNE-Club Meeting; SEP, 2017; Graz, AUSTRIA. Doi: 10.1016/j.freeradbiomed.2018.05.025 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Muller, HD; Posch, F; Gumpoldsberger, M; Suppan, C; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoger, H; Lax, S; Balic, M Prognostic impact of the Residual Cancer Burden (RCB) index on recurrence-free survival of breast cancer patients recieving neoadjuvant therapy
ONCOL RES TREAT. 2018; 41: 297-298. [Poster]
Web of Science

 

** Suppan, C; Brcic, I; Heitzer, E; Tiran, V; Mueller, HD; Auer, M; Cote, RJ; Datar, R; Dandachi, N; Balic, M Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment
EUR J CANCER. 2018; 92: S136-S136.-11th European Breast Cancer Conference (EBCC); MAR 21-23, 2018; Barcelona, SPAIN. [Poster]
Web of Science

 

2017

Originalarbeit (Zeitschrift)

** Benezeder, T; Tiran, V; Treitler, AAN; Suppan, C; Rossmann, C; Stoeger, H; Cote, RJ; Datar, RH; Balic, M; Dandachi, N Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients.
Oncotarget. 2017; 8(54):92483-92496 Doi: 10.18632/oncotarget.21426 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Dandachi, N; Tiran, V; Lindenmann, J; Brcic, L; Fink-Neuboeck, N; Kashofer, K; Absenger, G; Bezan, A; Cote, RJ; Datar, R; Balic, M Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Lung Cancer. 2017; 113(46):152-157 Doi: 10.1016/j.lungcan.2017.10.003
Web of Science PubMed FullText FullText_MUG

 

** Tiran, V; Lindenmann, J; Brcic, L; Heitzer, E; Stanzer, S; Tabrizi-Wizsy, NG; Stacher, E; Stoeger, H; Popper, HH; Balic, M; Dandachi, N Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.
Sci Rep. 2017; 7(1):10040-10040 Doi: 10.1038/s41598-017-09929-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Tiran, V; Stanzer, S; Heitzer, E; Meilinger, M; Rossmann, C; Lax, S; Tsybrovskyy, O; Dandachi, N; Balic, M Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
PLoS One. 2017; 12(4):e0175223-e0175223 Doi: 10.1371/journal.pone.0175223 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Suppan, C; Tiran, V; Heitzer, E; Auer, M; Cote, RJ; Datar, RH; Dandachi, N; Balic, M Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis
EUR J CANCER. 2017; 72: S39-S40. Doi: 10.1016/S0959-8049(17)30211-3 [Poster]
Web of Science FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Suppan, C; Bjelic-Radisic, V; La Garde, M; Groselj-Strele, A; Eberhard, K; Samonigg, H; Loibner, H; Dandachi, N; Balic, M Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.
BMC Cancer. 2015; 15:1027-1027 Doi: 10.1186/s12885-015-2005-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Originalarbeit (Zeitschrift)

** Heitzer, E; Artl, M; Filipits, M; Resel, M; Graf, R; Weißenbacher, B; Lax, S; Gnant, M; Wrba, F; Greil, R; Dietze, O; Hofbauer, F; Böhm, G; Höfler, G; Samonigg, H; Schaberl-Moser, R; Balic, M; Dandachi, N Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
Mod Pathol. 2014; 27(6):906-915 Doi: 10.1038/modpathol.2013.204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Stadelmeyer, E; Heitzer, E; Resel, M; Cerroni, L; Wolf, P; Dandachi, N The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.
J Invest Dermatol. 2014; 134(2):548-550 Doi: 10.1038/jid.2013.338 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Sereinigg, M; Puntschart, A; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Stadelmeyer, E; Dandachi, N; Stadlbauer-K, V; Iberer, F; Stiegler, P Oxidative Stress and Apoptosis in a Pig Model of Brain Death (BD) and Living Donation (LD).
AM J TRANSPLANT. 2014; 14: 372-372.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA. [Poster]
Web of Science

 

** Sereinigg, M; Puntschart, A; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Stadelmeyer, E; Dandachi, N; Stadlbauer-K, V; Iberer, F; Stiegler, P; Oxidative Stress and Apoptosis in a Pig Model of Brain Death (BD) and Living Donation (LD).
TRANSPLANTATION. 2014; 98: 372-372.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA. [Poster]
Web of Science

 

** Suppan, C; Bjelic-Radisic, V; La Garde, M; Samonigg, H; Dandachi, N; Balic, M N/L Ratio does not have predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
EUR J CANCER. 2014; 50: S193-S193.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

** Suppan, C; Milkovic, L; Gasparovic, AC; Samonigg, H; Dandachi, N; Balic, M Higher levels of HNE are associated with disease aggressiveness and worse outcome in breast cancer patients
EUR J CANCER. 2014; 50: S70-S70.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

2013

Originalarbeit (Zeitschrift)

** Balic, M; Schwarzenbacher, D; Stanzer, S; Heitzer, E; Auer, M; Geigl, JB; Cote, RJ; Datar, RH; Dandachi, N Genetic and epigenetic analysis of putative breast cancer stem cell models.
BMC Cancer. 2013; 13(7):358-358 Doi: 10.1186/1471-2407-13-358 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Buxhofer-Ausch, V; Ausch, C; Zeillinger, R; Oberkanins, C; Dandachi, N; Reiner-Concin, A; Kriegshäuser, G Duplex reverse-hybridization assay for the simultaneous detection of KRAS/BRAF mutations in FFPE-extracted genomic DNA from colorectal cancer specimens.
Dis Markers. 2013; 34(3):171-177 Doi: 10.3233/DMA-120960 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hofmann, G; Balic, M; Dandachi, N; Resel, M; Schippinger, W; Regitnig, P; Samonigg, H; Bauernhofer, T The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Clin Biochem. 2013; 46(15):1585-1589 Doi: 10.1016/j.clinbiochem.2013.06.010
Web of Science PubMed FullText FullText_MUG

 

** Stiegler, P; Sereinigg, M; Puntschart, A; Bradatsch, A; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Stadelmeyer, E; Dandachi, N; Zelzer, S; Iberer, F; Stadlbauer, V Oxidative stress and apoptosis in a pig model of brain death (BD) and living donation (LD).
J Transl Med. 2013; 11(10):244-244 Doi: 10.1186/1479-5876-11-244 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Stiegler, P; Sereinigg, M; Puntschart, A; Bradatsch, A; Stanzer, S; Stadlmeyer, E; Dandachi, N; Leber, B; Wiederstein-Grasser, I; Iberer, F; Tscheliessnigg, KH; Stadlbauer, V Characterization of Different Gene Families Encoding for Pro-Apoptotic and Anti-Apoptotic as well as Genes Encoding for Oxidative Stress induced Cell Damage in Organ Transplantation: An Animal Study.
American Journal of Transplantation; Supplement 5. 2013; 13(5):400-400.-American Transplant Congress; May 18 - 22, 2013; Seattle, USA. [Poster]
Web of Science

 

** Stiegler, P; Sereinigg, M; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Iberer, F; Stadelmeyer, E; Dandachi, N; Stadlbauer-Kollner, V OXIDATIVE STRESS AND APOPTOSIS IN A PIG MODEL OF BRAIN DEATH (BD) AND LIVING DONATION (LD)
TRANSPL INT. . 2013; 26: 222-223. [Poster]
Web of Science

 

** Suppan, C; Bjelic-Radisic, V; La Guarde, M; Dandachi, N; Balic, M Neutrophil/Lymphocyte Ratio does not have predictive or prognostic value in breast cancer patients undergoing neoadjuvant systemic therapy
ONKOLOGIE. 2013; 36: 158-158. [Poster]
Web of Science

 

** Suppan, C; Milkovic, L; Gasparovic, AC; Waeg, G; Dandachi, N; Balic, M Higher levels of HNE are associated with disease aggressiveness and worse outcome of breast cancer patients
ONKOLOGIE. 2013; 36: 176-176.
Web of Science

 

2012

Originalarbeit (Zeitschrift)

** Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Mol Genet Genomics. 2012; 287(9):755-764 Doi: 10.1007/s00438-012-0715-7
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Heitzer, E; Marija, B; Resel, M; Graf, R; Weissenbacher, B; Schaberl-Moser, R; Dandachi, N; IDENTIFICATION OF PROGNOSTIC METHYLATION MARKERS IN PATIENTS WITH EARLY STAGE COLORECTAL CANCER.
ANN ONCOL. 2012; 23: 87-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

** Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Winder, T; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

2011

Originalarbeit (Zeitschrift)

** Balic, M; Rapp, N; Stanzer, S; Lin, H; Strutz, J; Szkandera, J; Daidone, MG; Samonigg, H; Cote, RJ; Dandachi, N Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.
Appl Immunohistochem Mol Morphol. 2011; 19(1):33-40 Doi: 10.1097/PAI.0b013e3181ebf4e8
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Stadelmeyer, E; Heitzer, E; Wolf, P; Dandachi, N COLD-HRM PCR versus Conventional HRM PCR to Detect the BRAF V600E Mutation A Real Improvement?
J MOL DIAGN. 2011; 13(2): 243-243. Doi: 10.1016/j.jmoldx.2010.09.005 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Originalarbeit (Zeitschrift)

** Balic, M; Williams, A; Dandachi, N; Cote, RJ Micrometastasis: detection methods and clinical importance.
Cancer Biomark. 2010; 9(1-6):397-419 Doi: 10.3233/CBM-2011-0161
Web of Science PubMed FullText FullText_MUG

 

** Stanzer, S; Balic, M; Strutz, J; Heitzer, E; Obermair, F; Hauser-Kronberger, C; Samonigg, H; Dandachi, N Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis.
Clin Biochem. 2010; 43(18):1443-1448 Doi: 10.1016/j.clinbiochem.2010.09.013
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Heitzer, E; Bambach, I; Dandachi, N; Horn, M; Wolf, P PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches.
EXP DERMATOL. 2010; 19(10): 926-928. Doi: 10.1111/j.1600-0625.2010.01120.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Originalarbeit (Zeitschrift)

** Ausch, C; Buxhofer-Ausch, V; Oberkanins, C; Holzer, B; Minai-Pour, M; Jahn, S; Dandachi, N; Zeillinger, R; Kriegshäuser, G Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
J Mol Diagn. 2009; 11(6):508-513 Doi: 10.2353/jmoldx.2009.090022 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Balic, M; Pichler, M; Strutz, J; Heitzer, E; Ausch, C; Samonigg, H; Cote, RJ; Dandachi, N High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.
J Mol Diagn. 2009; 11(2):102-108 Doi: 10.2353/jmoldx.2009.080109 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Pichler, M; Balic, M; Stadelmeyer, E; Ausch, C; Wild, M; Guelly, C; Bauernhofer, T; Samonigg, H; Hoefler, G; Dandachi, N Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.
J Mol Diagn. 2009; 11(2):140-147 Doi: 10.2353/jmoldx.2009.080100 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Stiegler, P; Schweiger, M; Sereinigg, M; Seifert, T; Marko, T; Lackner, C; Dandachi, N; Stanzer, S; Iberer, F; Greilberger, J; Hallström, S; Tscheliessnigg, KH Prevention of oxidative stress induced organ damage in a porcine brain dead donor model
Transplant International2009; 22(2):57-57.-ESOT; European Society of Organ Transplantation; Aug 8-Sept 2, 2009; Paris, FRANCE. [Oral Communication]
Web of Science

 

** Stiegler, P; Schweiger, M; Sereinigg, M; Stanzer, S; Dandachi, N; Seifert, T; Marko, T; Greilberger, J; Iberer, F; Tscheliessnigg, KH Establishing a brain dead donor model in pigs.
Transplant International2009; 22(2):346-346.-ESOT, European Society of Organ Transplantation; Aug 28-Sept 2, 2009; Paris, FRANCE. [Poster]
Web of Science

 

2008

Originalarbeit (Zeitschrift)

** Stanzer, S; Dandachi, N; Balic, M; Resel, M; Samonigg, H; Bauernhofer, T Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.
J Clin Immunol. 2008; 28(2):107-114 Doi: 10.1007/s10875-007-9139-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stefatic, D; Riederer, M; Balic, M; Dandachi, N; Stanzer, S; Janesch, B; Resel, M; Ler, D; Samonigg, H; Bauernhofer, T Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum.
Bosn J Basic Med Sci. 2008; 8(3):245-250 Doi: 10.17305/bjbms.2008.2926 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Stanzer, S; Dandachi, N; Balic, M; Bauernhofer, T; Samonigg, H The role of NKG2D expression and soluble MICA and MICB in the higher onset of apoptosis of NK cell subsets in patients with epithelial cancer
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A46-A46. [Poster]
Web of Science

 

2007

Originalarbeit (Zeitschrift)

** Ausch, C; Dandachi, N; Buxhofer-Ausch, V; Balic, M; Huber, K; Bauernhofer, T; Ogris, E; Hinterberger, W; Braun, S; Schiessel, R Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer.
Clin Chem Lab Med. 2007; 45(3):351-356 Doi: 10.1515/CCLM.2007.059
Web of Science PubMed FullText FullText_MUG

 

** Schippinger, W; Dandachi, N; Regitnig, P; Hofmann, G; Balic, M; Neumann, R; Samonigg, H; Bauernhofer, T The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.
Am J Clin Pathol. 2007; 128(4):630-637 Doi: 10.1309/51KPD70348RP6XTE [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T Frequency of febrile neutropenia in patients treated with taxane/epirubicine and colony-stimulating growth factors for breast cancer: comparison of filgrastim/lenograstim with pegfilgrastim
BREAST CANCER RES. 2007; 9(1): Doi: 10.1186/bcr1722 [Poster]
Web of Science FullText FullText_MUG

 

2006

Originalarbeit (Zeitschrift)

** Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T; Samonigg, H Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
Oncology. 2006; 70(4):290-293 Doi: 10.1159/000094890
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schippinger, W; Regitnig, P; Dandachi, N; Wernecke, KD; Bauernhofer, T; Samonigg, H; Moinfar, F Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer.
Virchows Arch. 2006; 449(1):24-30 Doi: 10.1007/s00428-006-0213-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Balic, M; Dandachi, N; Lin, H; Datar, RH Cancer metastasis: advances in the detection and characterization of disseminated tumour cells facilitate clinical translation.
Natl Med J India. 2006; 18(5):250-255
Web of Science PubMed

 

2005

Originalarbeit (Zeitschrift)

** Balic, M; Dandachi, N; Hofmann, G; Samonigg, H; Loibner, H; Obwaller, A; van der Kooi, A; Tibbe, AG; Doyle, GV; Terstappen, LW; Bauernhofer, T Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
Cytometry B Clin Cytom. 2005; 68(1):25-30 Doi: 10.1002/cyto.b.20065 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Bauernhofer, T; Zenahlik, S; Hofmann, G; Balic, M; Resel, M; Pirchmoser, R; Regitnig, P; Ambros, P; Dandachi, N; Samonigg, H Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
Oncol Rep. 2005; 13(2):179-184
Web of Science PubMed FullText Google Scholar

 

** Dandachi, N; Balic, M; Stanzer, S; Halm, M; Resel, M; Hinterleitner, TA; Samonigg, H; Bauernhofer, T Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.
J Mol Diagn. 2005; 7(5):631-637 Doi: 10.1016/S1525-1578(10)60597-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Wernecke, KD; Samonigg, H; Bauernhofer, T Quantitative measurement of soluble E-cadherin in sera of breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy and its predictive and prognostic value.
J CLIN ONCOL 2005 23: 70S-70S.
Web of Science

 

** Samonigg, H; Himmler, G; Gnant, M; Gastl, G; Loibner, H; Possinger, K; Bauernhofer, T; Dandachi, N; Balic, M; Steger, G; Obwaller, A A multicenter phase II, open-label trial of multiple doses of cancer vaccine candidate IGN101 to evaluate efficacy against disseminated tumor cells in blood.
J CLIN ONCOL 2005 23: 180S-180S.
Web of Science

 

2004

Originalarbeit (Zeitschrift)

** Biedermann, K; Dandachi, N; Trattner, M; Vogl, G; Doppelmayr, H; Moré, E; Staudach, A; Dietze, O; Hauser-Kronberger, C Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue.
J Clin Microbiol. 2004; 42(8):3758-3765 Doi: 10.1128/JCM.42.8.3758-3765.2004 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Dandachi, N; Dietze, O; Hauser-Kronberger, C Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer.
ANTICANCER RES. 2004; 24: 2401-2406. [OPEN ACCESS]
Web of Science PubMed FullText

 

** Hauser-Kronberger, C; Dandachi, N Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assessment in breast cancer.
J MOL HISTOL. 2004; 35: 647-653. Doi: 10.1007/s10735-004-2186-6
Web of Science PubMed FullText FullText_MUG

 

2003

Originalarbeit (Zeitschrift)

** Hutarew, G; Dandachi, N; Strasser, F; Prokop, E; Dietze, O Two-year evaluation of telepathology.
J Telemed Telecare. 2003; 9(4):194-199 Doi: 10.1258/135763303322225508
Web of Science PubMed FullText FullText_MUG

 

** Moré, E; Fellner, T; Doppelmayr, H; Hauser-Kronberger, C; Dandachi, N; Obrist, P; Sandhofer, F; Paulweber, B Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) expression in human breast cancer cell lines.
J Endocrinol. 2003; 176(1): 83-94. Doi: 10.1677/joe.0.1760083 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Obwaller, A; Balic, M; van der Kooi, A; Dandachi, N; Himmler, G; Mudde, GC; Peball, B; Grunt, S; Oberkleiner, P; Doyle, GV; Terstappen, LWMM; Bauernhofer, T; Samonigg, H; Loibner, H Comparative analysis of three different methods for the detection of disseminated tumor cells
J IMMUNOTHER 2003 26: S49-S50.
Web of Science

 

2002

Originalarbeit (Zeitschrift)

** Dandachi, N; Dietze, O; Hauser-Kronberger, C Chromogenic in situ hybridization: a novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma.
Lab Invest. 2002; 82(8):1007-1014 Doi: 10.1097/01.LAB.0000024360.48464.A4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2001

Originalarbeit (Zeitschrift)

** Dandachi, N; Hauser-Kronberger, C; Moré, E; Wiesener, B; Hacker, GW; Dietze, O; Wirl, G Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.
J Pathol. 2001; 193(2):181-189 Doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V
Web of Science PubMed FullText FullText_MUG

 

** Trattner, M; Graf, AH; Lax, S; Forstner, R; Dandachi, N; Haas, J; Pickel, H; Reich, O; Staudach, A; Winter, R Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Gynecol Oncol. 2001; 82(1):11-16 Doi: 10.1006/gyno.2001.6252
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Originalarbeit (Zeitschrift)

** Graf, AH; Cheung, AL; Hauser-Kornberger, C; Dandachi, N; Tubbs, RR; Dietze, O; Hacker, GW Clinical relevance of HPV 16/18 testing methods in cervical squamous cell carcinoma.
Appl Immunohistochem Mol Morphol. 2000; 8(4):300-309 Doi: 10.1097/00022744-200012000-00007
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum